|
JPS4632671B1
(cg-RX-API-DMAC7.html)
*
|
1969-10-13 |
1971-09-23 |
Eisai Co Ltd |
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
CY1308A
(en)
|
1979-12-06 |
1985-12-06 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
|
CY1492A
(en)
|
1981-07-08 |
1990-02-16 |
Draco Ab |
Powder inhalator
|
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
|
AT396333B
(de)
|
1982-10-08 |
1993-08-25 |
Glaxo Group Ltd |
Vorrichtung zur verabreichung von medikamenten an patienten, einrichtung mit mehreren solchen vorrichtungen und traeger mit medikamentbehaeltern hiefuer
|
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
|
GR861995B
(en)
|
1985-07-30 |
1986-11-04 |
Glaxo Group Ltd |
Devices for administering medicaments to patients
|
|
JPH0733379B2
(ja)
*
|
1986-06-27 |
1995-04-12 |
エーザイ株式会社 |
光学活性α−トコフエロ−ルの製造方法
|
|
SK280968B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
IL115849A0
(en)
|
1994-11-03 |
1996-01-31 |
Merz & Co Gmbh & Co |
Tangential filtration preparation of liposomal drugs and liposome product thereof
|
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
|
US5827533A
(en)
|
1997-02-06 |
1998-10-27 |
Duke University |
Liposomes containing active agents aggregated with lipid surfactants
|
|
FR2798656B1
(fr)
|
1999-09-17 |
2004-12-17 |
Aventis Pharma Sa |
Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
|
|
WO2002007572A1
(fr)
|
2000-07-21 |
2002-01-31 |
Ljudmila Petrovna Maljuk |
Assiette pour repas consommes debout
|
|
EP1305308B1
(en)
|
2000-07-26 |
2006-12-20 |
Smithkline Beecham Plc |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
|
|
FR2816618B1
(fr)
|
2000-11-15 |
2002-12-27 |
Aventis Pharma Sa |
Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
|
|
GB0031088D0
(en)
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
EP1345903A1
(en)
|
2000-12-21 |
2003-09-24 |
Ciba SC Holding AG |
Crystalline forms of cerivastatin sodium
|
|
GB0101577D0
(en)
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
|
GB0112836D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0112834D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0118238D0
(en)
|
2001-07-26 |
2001-09-19 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
WO2003064421A1
(en)
|
2002-01-29 |
2003-08-07 |
Glaxo Group Limited |
Aminopiperidine derivatives
|
|
JP4508650B2
(ja)
|
2002-01-29 |
2010-07-21 |
グラクソ グループ リミテッド |
アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
|
|
US20060014786A1
(en)
*
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
|
TW200406413A
(en)
|
2002-06-26 |
2004-05-01 |
Glaxo Group Ltd |
Compounds
|
|
TW200409637A
(en)
|
2002-06-26 |
2004-06-16 |
Glaxo Group Ltd |
Compounds
|
|
WO2004002990A2
(en)
|
2002-06-27 |
2004-01-08 |
F. Hoffmann-La Roche Ag |
Synthesis of purine derivatives
|
|
GB0217294D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicaments
|
|
FR2844270B1
(fr)
|
2002-09-11 |
2006-05-19 |
Aventis Pharma Sa |
Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
|
|
FR2844268B1
(fr)
|
2002-09-11 |
2004-10-22 |
Aventis Pharma Sa |
Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
|
|
CN101817815A
(zh)
|
2002-10-10 |
2010-09-01 |
莫弗凯姆联合化学股份公司 |
具有杀菌活性的化合物
|
|
AU2003291227A1
(en)
|
2002-11-05 |
2004-06-07 |
Smithkline Beecham Corporation |
Antibacterial agents
|
|
ES2340484T3
(es)
|
2002-11-05 |
2010-06-04 |
Glaxo Group Limited |
Agentes antibacterianos.
|
|
AR042486A1
(es)
|
2002-12-18 |
2005-06-22 |
Glaxo Group Ltd |
Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
|
|
TW200507841A
(en)
|
2003-03-27 |
2005-03-01 |
Glaxo Group Ltd |
Antibacterial agents
|
|
FR2852954B1
(fr)
|
2003-03-28 |
2006-07-14 |
Aventis Pharma Sa |
Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE10316081A1
(de)
|
2003-04-08 |
2004-10-21 |
Morphochem AG Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
|
FR2858619B1
(fr)
|
2003-08-08 |
2006-12-22 |
Aventis Pharma Sa |
Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
|
|
KR101376715B1
(ko)
|
2003-12-19 |
2014-03-27 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된 마이크로- 및 나노- 구조를 제작하는 방법
|
|
US9214590B2
(en)
|
2003-12-19 |
2015-12-15 |
The University Of North Carolina At Chapel Hill |
High fidelity nano-structures and arrays for photovoltaics and methods of making the same
|
|
US8158728B2
(en)
|
2004-02-13 |
2012-04-17 |
The University Of North Carolina At Chapel Hill |
Methods and materials for fabricating microfluidic devices
|
|
FR2867472B1
(fr)
|
2004-03-12 |
2008-07-18 |
Aventis Pharma Sa |
Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2008502689A
(ja)
|
2004-06-15 |
2008-01-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
FR2872164B1
(fr)
|
2004-06-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2008505920A
(ja)
|
2004-07-08 |
2008-02-28 |
グラクソ グループ リミテッド |
抗菌剤
|
|
EP1773847A2
(en)
*
|
2004-07-09 |
2007-04-18 |
Glaxo Group Limited |
Antibacterial agents
|
|
JP2008506695A
(ja)
|
2004-07-13 |
2008-03-06 |
グラクソ グループ リミテッド |
抗細菌剤
|
|
JP2008507543A
(ja)
|
2004-07-22 |
2008-03-13 |
グラクソ グループ リミテッド |
抗細菌剤
|
|
WO2006017468A2
(en)
|
2004-08-02 |
2006-02-16 |
Glaxo Group Limited |
Antibacterial agents
|
|
EP1784410A4
(en)
|
2004-08-09 |
2009-07-15 |
Glaxo Group Ltd |
ANTIBACTERIAL AGENTS
|
|
DE102004041163A1
(de)
|
2004-08-25 |
2006-03-02 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
|
WO2006032466A2
(en)
|
2004-09-24 |
2006-03-30 |
Actelion Pharmaceuticals Ltd |
New bicyclic antibiotics
|
|
DE602005021133D1
(de)
|
2004-10-05 |
2010-06-17 |
Actelion Pharmaceuticals Ltd |
Neue piperidin-antibiotika
|
|
JP5314244B2
(ja)
|
2004-10-27 |
2013-10-16 |
富山化学工業株式会社 |
新規な含窒素複素環化合物およびその塩
|
|
EP1846417A4
(en)
|
2005-01-25 |
2009-12-23 |
Glaxo Group Ltd |
ANTIBACTERIAL ACTIVE SUBSTANCES
|
|
EP1891078A1
(en)
|
2005-05-24 |
2008-02-27 |
AstraZeneca AB |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
|
|
MY150958A
(en)
|
2005-06-16 |
2014-03-31 |
Astrazeneca Ab |
Compounds for the treatment of multi-drug resistant bacterial infections
|
|
EP2468743A1
(en)
|
2005-06-24 |
2012-06-27 |
Toyama Chemical Co., Ltd. |
Nitrogen-containing bicyclic compounds useful as antibacterial agents
|
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
|
DOP2006000268A
(es)
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
|
US8944804B2
(en)
|
2006-01-04 |
2015-02-03 |
Liquidia Technologies, Inc. |
Nanostructured surfaces for biomedical/biomaterial applications and processes thereof
|
|
DE602007010427D1
(de)
*
|
2006-02-15 |
2010-12-23 |
Actelion Pharmaceuticals Ltd |
Antibiotische ethanol- oder 1,2-ethandiol-cyclohexyl-derivate
|
|
AU2007268749B2
(en)
|
2006-05-26 |
2012-07-26 |
Taisho Pharmaceutical Co., Ltd. |
Novel heterocyclic compound or salt thereof and intermediate thereof
|
|
EP1992628A1
(en)
*
|
2007-05-18 |
2008-11-19 |
Glaxo Group Limited |
Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
|
|
US8465775B2
(en)
|
2006-07-27 |
2013-06-18 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
|
|
US8128393B2
(en)
|
2006-12-04 |
2012-03-06 |
Liquidia Technologies, Inc. |
Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom
|
|
CL2007003693A1
(es)
*
|
2006-12-22 |
2008-06-27 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
|
|
GB0707704D0
(en)
*
|
2007-04-20 |
2007-05-30 |
Glaxo Group Ltd |
Compounds
|
|
WO2009024342A2
(en)
*
|
2007-08-23 |
2009-02-26 |
Syngenta Participations Ag |
Novel microbiocides
|
|
US7976759B2
(en)
|
2007-10-12 |
2011-07-12 |
Liquidia Technologies, Inc. |
System and method for producing particles and patterned films
|
|
JP5620636B2
(ja)
|
2007-11-26 |
2014-11-05 |
富山化学工業株式会社 |
新規な複素環化合物またはその塩を含有する抗菌剤
|
|
AR073774A1
(es)
*
|
2008-10-07 |
2010-12-01 |
Actelion Pharmaceuticals Ltd |
Compuestos antibioticos oxazolidinona triciclicos
|
|
WO2010045987A1
(en)
*
|
2008-10-23 |
2010-04-29 |
Glaxo Group Limited |
Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
|
|
TW201022279A
(en)
*
|
2008-11-14 |
2010-06-16 |
Astrazeneca Ab |
Chemical compounds
|
|
BRPI0923282B1
(pt)
|
2008-12-05 |
2019-09-03 |
Liquidia Tech Inc |
método para a produção de materiais padronizados
|
|
NZ593891A
(en)
*
|
2008-12-12 |
2013-05-31 |
Actelion Pharmaceuticals Ltd |
5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
|
|
WO2011008737A2
(en)
|
2009-07-13 |
2011-01-20 |
The University Of North Carolina At Chapel Hill |
Engineered aerosol particles, and associated methods
|
|
TW201209056A
(en)
*
|
2010-05-25 |
2012-03-01 |
Taisho Pharmaceutical Co Ltd |
Novel heterocyclic compound or salt thereof
|
|
CA2840060A1
(en)
*
|
2011-06-27 |
2013-01-03 |
Kyorin Pharmaceutical Co., Ltd. |
Bridged bicyclic compounds for the treatment of bacterial infections
|
|
EP2785721A1
(en)
*
|
2011-11-30 |
2014-10-08 |
Actelion Pharmaceuticals Ltd. |
3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
|
|
HK1221459A1
(zh)
|
2013-04-16 |
2017-06-02 |
Idorsia Pharmaceuticals Ltd |
抗菌双芳香族衍生物
|
|
TW201722965A
(zh)
*
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|